Gilteritinib 40mg tablets
NHS hospitals in England used £16,643,257 of indicative cost of Gilteritinib 40mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 9.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Gilteritinib 40mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Gilteritinib 40mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Barts Health Nhs Trust | £1,578,415 |
| The Royal Marsden Nhs Foundation Trust | £1,075,937 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,027,448 |
| Cambridge Univ Hosp Nhs Foundation Trust | £813,445 |
| The Clatterbridge Cancer Centre Nhs Ft | £759,058 |
| Univ Hpls Bristol Nhs Foundation Trust | £646,736 |
| Leeds Teaching Hpls Nhs Trust | £618,867 |
| Imperial College Healthcare Nhs Trust | £572,249 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £563,804 |
| King's College Hpl Nhs Foundation Trust | £562,791 |
The primary-care picture
Gilteritinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Gilteritinib medicine page.